Primary Record
Aloxistatin
- In stock
- 1,603 g
- Purity
- 99.0 %
- CAS
- 88321-09-9
Compound Identifiers & Properties
- CAS
- 88321-09-9
- PubChem CID
- 65663
- SMILES
- CCOC(=O)[C@@H]1[C@H](O1)C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C
- Canonical SMILES
- CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C
Names & Synonyms
- Aloxistatin
- Loxistatin
- E-64D
- Aloxistatina
- Aloxistatine
- Aloxistatinum
- 88321-09-9
- Aloxistatin [INN]
- estat
- E 64c ethyl ester
- Estate
- E 64d
- EST (pharmaceutical)
- Aloxistatine [French]
- Aloxistatinum [Latin]
- Aloxistatina [Spanish]
- E64d
- E-64c ethyl ester
- Aloxistatin (E64D)
- L5W337AOUR
- E-64d(Aloxistatin)?
- Opera_ID_506
- UNII-L5W337AOUR
- protease inhibitor E64d
- MFCD00132883
- E-64-d
- LOXISTATIN [JAN]
- RefChem:110983
- CCRIS 1934
- GlyTouCan:G43737XK
- C17H30N2O5
- CHEMBL63440
- D0NJ1A
- AC1L23PT
- E-64d, protease inhibitor
- MLS000028372
- CBiol_001881
- MLS006010826
- NSC-694281
- SCHEMBL483320
- CHEBI:101381
- DTXSID00904150
- EP 453
- orb1301127
- NSC 694281
- GTPL10714
- BRN 5354546
- EX-A860
- EP-453
- SRVFFFJZQVENJC-IHRRRGAJSA-N
- Bio1_000167
- Bio1_000656
- Bio1_001145
- DTXCID701332035
- EP453
- GLXC-07973
- HMS2236F06
- HMS3403C21
- HMS3886N13
- E-64d [for Biochemical Research]
- CID65663
- G43737XK
- ZINC3913912
- BDBM50052693
- NSC694281
- s7393
- SMR000058552
- AKOS024458215
- C17-H30-N2-O5
- compound 2b [PMID: 8765519]
- ACN-053684
- BAT-015061
- CCG-207846
- CS-5996
- E-64d(Aloxistatin,Loxistatin pound(c)
- FD21942
- FE29623
- NCGC00167328-03
- AC-35497
- AS-55817
- DA-72979
- J22.181C
- QC-10414
- SY077973
- loxistatin, (2S-(2alpha,3beta(R*)))-
- EST - CAS 88321-09-9
- HY-100229
- LS-101008
- A1903
- E1337
- NS00125413
- X6849
- EST
- A13259
- C76913
- (2S-(2alpha,3beta(R*)))-isomer of loxistatin
- A858335
- Ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate
- L-trans-Epoxysuccinyl(OEt)-Leu-3-methylbutylamide
- L-trans-Epoxysuccinyl-Leu-3-methylbutylamide-ethyl ester
- SR-01000759197
- ethyl (2S,3S)-3-[[(2S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate
- SR-01000759197-2
- (2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester
- BRD-K91188791-001-12-6
- BRD-K91188791-001-14-2
- BRD-K91188791-001-15-9
- BRD-K91188791-001-18-3
- Epoxysuccinyl-leucylamide(3-methyl)butane ethyl ester
- Q27177634
- ethyl (2S,3S)-3-(((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-yl)carbamoyl)oxirane-2-carboxylate
- (2S,3S)-3-[[[(1S)-3-Methyl-1-[[(3-methylbutyl)amino]carbonyl]-butyl]amino]carbonyl]-2-oxiranecarboxylic acid ethyl ester
- ethyl (2S,3S)-3-[[(1S)-1-(isopentylcarbamoyl)-3-methyl-butyl]carbamoyl]oxirane-2-carboxylate
- (2S,3S)-3-[[[(1S)-3-Methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-2-oxiranecarboxylic acid ethyl ester
- (2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester EST
- (2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester,
- ethyl (2S,3S)-3-({(2S)-4-methyl-1-[(3-methylbutyl)amino]-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylate
- Oxiranecarboxylic acid, 3-((((1S)-3-methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino)carbonyl)-, ethyl ester, (2S,3S)-
- Oxiranecarboxylic acid, 3-(((3-methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino)carbonyl)-, ethyl ester, (2S-(2-alpha,3-beta(R*)))-
- Aloxistatin, 98%, irreversible cell-permeable cysteine protease inhibitor - 1MG 1mg
- Ethyl 3-(3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl)-2-oxiranecarboxylate
- (2S)-3beta-[[[(S)-3-Methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]oxirane-2alpha-carboxylic acid ethyl ester
- (2S,3S)-3-[(S)-3-Methyl-1-(3-methyl-butylcarbamoyl)-butylcarbamoyl]-oxirane-2-carboxylic acid ethyl ester
- (2S,3S)-3-[[[(1S)-3-Methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-2-oxiranecarboxylic Acid Ethyl Ester; Aloxistatin; E 64c ethyl ester; E 64d; EP 453; EST; EST (pharmaceutical); Loxistatin; NSC 694281; E-64d
- (2S,3S)-ethyl 3-(((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-yl)carbamoyl)oxirane-2-carboxylate
- (2S,3S)-ethyl 3-((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)oxirane-2-carboxylate
- [2S,3S,(+)]-3beta-[(S)-3-Methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl]-2alpha-oxiranecarboxylic acid ethyl ester
- 2-Oxiranecarboxylic acid, 3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-, ethyl ester, (2S,3S)-
- 3-[[[(1S)-3-Methyl-1[[(3S-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-2S-oxiranecarboxylic acid, ethyl ester
- 3-[3-Methyl-1-(3-methyl-butylcarbamoyl)-butylcarbamoyl]-oxirane-2-carboxylic acid ethyl ester
- ethyl (2S,3S)-3-(((2S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl)carbamoyl)oxirane-2-carboxylate
- ethyl (2S,3S)-3-(((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-yl)carbamoyl)oxirane-2-carboxyla
- ETHYL (2S,3S)-3-{[(1S)-3-METHYL-1-[(3-METHYLBUTYL)CARBAMOYL]BUTYL]CARBAMOYL}OXIRANE-2-CARBOXYLATE
- Nalpha-[[(2S)-3beta-(Ethoxycarbonyl)oxirane-2alpha-yl]carbonyl]-N-(3-methylbutyl)-L-leucinamide
- TE
- trans-Ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate